<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04761159</url>
  </required_header>
  <id_info>
    <org_study_id>Ketamin-propofol</org_study_id>
    <nct_id>NCT04761159</nct_id>
  </id_info>
  <brief_title>Ketamin Plus Propofol for Anesthesia Induction</brief_title>
  <official_title>Effect of Ketamin+Propofol Mixture on Postoperative Recovery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cukurova University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cukurova University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      ASA I-II 160 pediatric patients will recruit who underwent adenoidectomy-tonsillectomy&#xD;
      surgery. Propofol 1 mg/kg + ketamin1 mg/kg (1/1 ratio) for group I; propofol 1,5 mg/kg +&#xD;
      ketamin 0,75 mg/kg (2/1 ratio) for group II; propofol 2 mg/kg +ketamin 0,66 mg/kg (3/1 ratio)&#xD;
      for group III; propofol 3 mg/kg will perform for anesthesia induction. General anesthesia&#xD;
      will maintenance with sevoflurane 1-2% and O2/N2O mixture. Postoperative analgesia will&#xD;
      provide with tramadol 2mg/kg IV at last 30 min of surgery. Extubation time, length of stay in&#xD;
      PACU, PAED score, FLACC score, VAS score will record. Than all data will statistically&#xD;
      analyse.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      ASA I-II 160 pediatric patients will recruit who underwent adenoidectomy-tonsillectomy&#xD;
      surgery in this randomised controlled study. The participants will divide into the 4 groups&#xD;
      with computered random generation. The Different combination of propofol+ketamin mixture will&#xD;
      apply at the induction of anesthesia. The groups will assign as group I,II, III and IV.&#xD;
      Propofol 1 mg/kg + ketamin1 mg/kg (1/1 ratio) for group I; propofol 1,5 mg/kg + ketamin 0,75&#xD;
      mg/kg (2/1 ratio) for group II; propofol 2 mg/kg +ketamin 0,66 mg/kg (3/1 ratio) for group&#xD;
      III; propofol 3 mg/kg will perform for anesthesia induction. Fentanyl 1 microgram per kg and&#xD;
      rocuronium 0.6 mg/kg will apply for anesthesia induction to the all participants. General&#xD;
      anesthesia will maintenance with sevoflurane 1-2% and O2/N2O mixture. Postoperative analgesia&#xD;
      will provide with tramadol 2mg/kg IV at last 30 min of surgery. Extubation time, length of&#xD;
      stay in PACU, PAED score, FLACC score, VAS score will record. Than all data will&#xD;
      statistically analyse.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 15, 2021</start_date>
  <completion_date type="Anticipated">December 20, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 20, 2021</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomised, controlled</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>length of stay in PACU</measure>
    <time_frame>30 minutes in PACU</time_frame>
    <description>The participants will observe in PACU till the Aldrete score will achieve 15. This duration of time will record.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Anxiety score</measure>
    <time_frame>30 minutes in PACU</time_frame>
    <description>PAED scores will record till the patient discharge from the PACU.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Postoperative Recovery</condition>
  <arm_group>
    <arm_group_label>Ketofol1/1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Propofol 1 mg/kg + ketamin1 mg/kg (1/1 ratio) for group I to anesthesia induction.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ketofol1/2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>propofol 1,5 mg/kg + ketamin 0,75 mg/kg (2/1 ratio) for group II to anesthesia induction</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ketofol1/3</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>propofol 2 mg/kg +ketamin 0,66 mg/kg (3/1 ratio) for group III to anesthesia induction</description>
  </arm_group>
  <arm_group>
    <arm_group_label>propofol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>propofol 3 mg/kg will perform for anesthesia induction</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketamine</intervention_name>
    <description>Different mixture of ketamin-propofol will apply for anesthesia induction.</description>
    <arm_group_label>Ketofol1/1</arm_group_label>
    <arm_group_label>Ketofol1/2</arm_group_label>
    <arm_group_label>Ketofol1/3</arm_group_label>
    <arm_group_label>propofol</arm_group_label>
    <other_name>ketofol</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ASA I-II patients&#xD;
&#xD;
          -  Underwent adenoidectomy-tonsillectomy surgery&#xD;
&#xD;
          -  Age between 3-12&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  ASA III-IV patients&#xD;
&#xD;
          -  Age; under 3 years old&#xD;
&#xD;
          -  Age; above 12 years old.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Cukurova University</name>
      <address>
        <city>Adana</city>
        <zip>01380</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ebru Biricik, MD</last_name>
      <phone>05052420223</phone>
      <email>ebrubiricik01@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 28, 2021</study_first_submitted>
  <study_first_submitted_qc>February 17, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 18, 2021</study_first_posted>
  <last_update_submitted>August 11, 2021</last_update_submitted>
  <last_update_submitted_qc>August 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cukurova University</investigator_affiliation>
    <investigator_full_name>ebru biricik</investigator_full_name>
    <investigator_title>associate professor</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ketamine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

